Skip to content

The Neuroimaging Mechanism of Catgut Implantation at Acupoint in Treating BED Based on R-FMRI

The Neuroimaging Mechanism of Catgut Implantation at Acupoint in Treating BED Based on R-FMRI

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200005871
Enrollment
Unknown
Registered
2022-04-16
Start date
2022-06-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Binge Eating Disorder

Interventions

Control group:False catgut implantation at acupoint
Experimental group:Catgut implantation at acupoint

Sponsors

Nanjing Hospital of Traditional Chinese Medicine affiliated to Nanjing University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Those who meet the diagnosis of BED; 2.Aged 18 to 40 years; 3.No psychotherapy such as antidepressant or anti-anxiety treatment within 3 months; 4.Not receiving weight-loss treatment within 3 months; 5.Agree to accept the treatment according to this protocol and follow-up observation according to this program, and willing to cooperate in the completion of the test of various indicators, questionnaire survey, and willing to sign the informed consent.

Exclusion criteria

Exclusion criteria: 1.A current diagnosis of psychosis or bipolar disorder and/or a high level of suicide 2.Clinical conditions that affect weight and appetite regulation (e.g. hypothyroidism and Cushing syndrome, use of certain drugs that may affect food intake, such as appetite suppressants and diet drugs levothyrohormone sodium tablets, glucocorticoids, etc.) 3.A history of bleeding predisposition or clinical manifestations, including current use of anticoagulants; 4.Patients have various kinds of serious cardiovascular and cerebrovascular diseases; 5.Liver damage caused by other causes, pregnant women, cognitive impairment and poor compliance.

Design outcomes

Primary

MeasureTime frame
Fasting blood glucose;Triglycerides;Beck Anxiety Inventory;Positive and Negative Affect Schedule;Serotonin;Back Depression Inventory;Leptin;Functional magnetic resonance imaging;Yale-Brown Obsessive-Compulsive Scale;Yale food addiction scale;Ghrelin;

Secondary

MeasureTime frame
Waistline;

Countries

China

Contacts

Public ContactZhang Cairong
njszyyzcr@163.com+86 18951755167

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026